1. https://clinicaltrials.gov/ct2/results?term=alpharadin&cond=“Prostatic+Neoplasms”. Accessed 6 Jan 2020
2. Study of Radium-223 dichloride versus placebo and hormonal treatment as background therapy in subjects with bone predominant her2 (human epidermal growth factor receptor 2) negative hormone receptor positive metastatic breast cancer. https://clinicaltrials.gov/ct2/show/NCT02258464. Accessed 30 Dec 2019
3. Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients. https://clinicaltrials.gov/ct2/show/NCT02575963. Accessed 16 Dec 2019
4. Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma. https://clinicaltrials.gov/ct2/show/NCT02928029. Accessed 16 Dec 2019
5. Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma. https://clinicaltrials.gov/ct2/show/record/NCT01833520?term=NCT01833520. Accessed 9 Jan 2020